Improved cytotoxicity and preserved level of cell death induced in colon cancer cells by doxorubicin after its conjugation with iron-oxide magnetic nanoparticles

Toxicology in Vitro : an International Journal Published in Association with BIBRA
Ewa AugustinZofia Mazerska

Abstract

A promising strategy for overcoming the problem of limited efficacy in antitumor drug delivery and in drug release is the use of a nanoparticle-conjugated drug. Doxorubicin (Dox) anticancer chemotherapeutics has been widely studied in this respect, because of severe cardiotoxic side effects. Here, we investigated the cytotoxic effects, the uptake process, the changes in cell cycle progression and the cell death processes in the presence of iron-oxide magnetic nanoparticles (Nps) and doxorubicin conjugates (Dox-Nps) in human colon HT29 cells. The amount of Dox participated in biological action of Dox-Nps was determined by cyclic voltammetry and thermogravimetric measurements. The cytotoxicity of Dox-Nps was shown to be two/three times higher than free Dox, whereas Nps alone did not inhibit cell proliferation. Dox-Nps penetrated cancer cells with higher efficacy than free Dox, what could be a consequence of Dox-Nps aggregation with proteins in culture medium and/or with cell surface. The treatment of HT29 cells with Dox-Nps and Dox at IC50 concentration resulted in G2/M arrest followed by late apoptosis and necrosis. Summing up, the application of iron-oxide magnetic nanoparticles improved Dox-Nps cell penetration compared to fre...Continue Reading

References

Jul 25, 2006·Nature Reviews. Cancer·Andrew I Minchinton, Ian F Tannock
Sep 27, 2007·Journal of the National Cancer Institute·Olivier TrédanIan F Tannock
Sep 2, 2008·Nature Reviews. Drug Discovery·Mark E DavisDong M Shin
Mar 21, 2009·Bioorganic & Medicinal Chemistry·Amir H Faraji, Peter Wipf
May 19, 2009·Nanomedicine : Nanotechnology, Biology, and Medicine·Devika B ChithraniDavid A Jaffray
Dec 9, 2009·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Eun-Jung ParkKwangsik Park
Dec 4, 2010·Chemical Communications : Chem Comm·Shang-Hsiu HuSan-Yuan Chen
Jul 5, 2011·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Lei SunZhiwei Sun
Dec 6, 2011·Chemical Research in Toxicology·Masanori HorieHitoshi Iwahashi
Apr 10, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Yechezkel Barenholz
Aug 1, 2010·Therapeutic Delivery·Che-Ming Jack HuLiangfang Zhang
Jan 19, 2013·Biomacromolecules·Anna M NowickaZofia Mazerska
Feb 21, 2013·Chemical Communications : Chem Comm·Zane B StarkewolfTing Guo
Feb 21, 2013·Journal of Pharmaceutical Sciences·Ahu YuanYiqiao Hu
Apr 6, 2013·Journal of Pharmaceutical Sciences·Navid MosallaeiBizhan Malaekeh-Nikouei
Apr 6, 2013·Journal of Pharmaceutical Sciences·Khodadust RouhollahGunduz Ufuk
Aug 7, 2013·Molecular Pharmaceutics·Beata ChertokRobert Langer
Aug 3, 2014·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Eun-Jung ParkSang-Wook Kim
Oct 12, 2014·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Tianshi FengXuesi Chen
Feb 20, 2015·Nanomedicine·Cornelle W NoorlanderRobert E Geertsma

❮ Previous
Next ❯

Citations

Mar 20, 2020·Current Pharmaceutical Design·Nafis HaiderMohammad A Khan
Apr 24, 2021·Medicinal Research Reviews·Firdos A KhanFaheem H Pottoo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.